If approved, doravirine/islatravir would be the first two-drug HIV treatment regimen without an integrase inhibitor, ...

Gilead Sciences is pushing full speed ahead with its strategy to ensure global access to its long-acting HIV pre-exposure ...

Note that some links may require registration or subscription. The Department of Justice said it sent more than 20 subpoenas to doctors and clinics involved with transgender medical procedures on ...

A pivotal moment in the fight to end AIDS -- ensuring lifesaving innovation reaches those who need it most, wherever they live ...

Gilead Sciences GILD.O and the Global Fund to Fight AIDS, Tuberculosis and Malaria said yesterday they had finalized plans to supply a ...

UN officials warned that if the funding is not replaced, the world will see more than 4 million AIDS-related deaths and another 6 million HIV infections by 2029 ...